1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rheumatology Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Disease Modifying Anti-rheumatic Drugs
1.2.3 Nonsteroidal Anti-inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Uric Acid Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Rheumatology Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rheumatology Drugs Market Perspective (2017-2028)
2.2 Rheumatology Drugs Growth Trends by Region
2.2.1 Rheumatology Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Rheumatology Drugs Historic Market Size by Region (2017-2022)
2.2.3 Rheumatology Drugs Forecasted Market Size by Region (2023-2028)
2.3 Rheumatology Drugs Market Dynamics
2.3.1 Rheumatology Drugs Industry Trends
2.3.2 Rheumatology Drugs Market Drivers
2.3.3 Rheumatology Drugs Market Challenges
2.3.4 Rheumatology Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rheumatology Drugs Players by Revenue
3.1.1 Global Top Rheumatology Drugs Players by Revenue (2017-2022)
3.1.2 Global Rheumatology Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Rheumatology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rheumatology Drugs Revenue
3.4 Global Rheumatology Drugs Market Concentration Ratio
3.4.1 Global Rheumatology Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Drugs Revenue in 2021
3.5 Rheumatology Drugs Key Players Head office and Area Served
3.6 Key Players Rheumatology Drugs Product Solution and Service
3.7 Date of Enter into Rheumatology Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatology Drugs Breakdown Data by Type
4.1 Global Rheumatology Drugs Historic Market Size by Type (2017-2022)
4.2 Global Rheumatology Drugs Forecasted Market Size by Type (2023-2028)
5 Rheumatology Drugs Breakdown Data by Application
5.1 Global Rheumatology Drugs Historic Market Size by Application (2017-2022)
5.2 Global Rheumatology Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Rheumatology Drugs Market Size (2017-2028)
6.2 North America Rheumatology Drugs Market Size by Country (2017-2022)
6.3 North America Rheumatology Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Rheumatology Drugs Market Size (2017-2028)
7.2 Europe Rheumatology Drugs Market Size by Country (2017-2022)
7.3 Europe Rheumatology Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rheumatology Drugs Market Size (2017-2028)
8.2 Asia-Pacific Rheumatology Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Rheumatology Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Rheumatology Drugs Market Size (2017-2028)
9.2 Latin America Rheumatology Drugs Market Size by Country (2017-2022)
9.3 Latin America Rheumatology Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rheumatology Drugs Market Size (2017-2028)
10.2 Middle East & Africa Rheumatology Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Rheumatology Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Detail
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Rheumatology Drugs Introduction
11.1.4 Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2017-2022)
11.1.5 Takeda Pharmaceutical Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Rheumatology Drugs Introduction
11.2.4 Sanofi Revenue in Rheumatology Drugs Business (2017-2022)
11.2.5 Sanofi Recent Development
11.3 Genentech
11.3.1 Genentech Company Detail
11.3.2 Genentech Business Overview
11.3.3 Genentech Rheumatology Drugs Introduction
11.3.4 Genentech Revenue in Rheumatology Drugs Business (2017-2022)
11.3.5 Genentech Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Rheumatology Drugs Introduction
11.4.4 Novartis Revenue in Rheumatology Drugs Business (2017-2022)
11.4.5 Novartis Recent Development
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Detail
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Rheumatology Drugs Introduction
11.5.4 Janssen Biotech Revenue in Rheumatology Drugs Business (2017-2022)
11.5.5 Janssen Biotech Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Rheumatology Drugs Introduction
11.6.4 Amgen Revenue in Rheumatology Drugs Business (2017-2022)
11.6.5 Amgen Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Rheumatology Drugs Introduction
11.7.4 AbbVie Revenue in Rheumatology Drugs Business (2017-2022)
11.7.5 AbbVie Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Rheumatology Drugs Introduction
11.8.4 Pfizer Revenue in Rheumatology Drugs Business (2017-2022)
11.8.5 Pfizer Recent Development
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Detail
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Introduction
11.9.4 Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2017-2022)
11.9.5 Bristol-Myers Squibb Company Recent Development
11.10 Merck & Co.
11.10.1 Merck & Co. Company Detail
11.10.2 Merck & Co. Business Overview
11.10.3 Merck & Co. Rheumatology Drugs Introduction
11.10.4 Merck & Co. Revenue in Rheumatology Drugs Business (2017-2022)
11.10.5 Merck & Co. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
